Substantia Nigra Susceptibility-To-Volume Ratio Derived From QSM as a Marker for Discrimination of Progressive Supranuclear Palsy From Parkinson's Disease and Multiple System Atrophy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 피인용
- Web of Science 1Scopus 1
- FWCI (Scopus)
- 2.08
- JCR IF
- JCR 2024 3.5
- ISSN
- 1053-1807
저자
- Candan, Huseyin Enes제1저자Ulsan Natl Inst Sci & Technol, Grad Sch Hlth Sci & Technol, Ulsan, South Korea
- Jo, SungyangUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Myratgeldyyev, NepesUlsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea
- Tessema, Abel WorkuUlsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea
- Lee, HansolUlsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan, South Korea
- 이재혁Pusan Natl Univ, Yangsan Hosp, Sch Med, Dept Neurol, Yangsan, South Korea
- Lee, HyoyoungUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Lee, Grace YoojinUniv Ulsan, Coll Med, Asan Med Inst Convergence Sci & Technol, Asan Med Ctr,Dept Med Sci, Seoul, South Korea
- Suh, Chong HyunUniv Ulsan, Asan Med Ctr, Coll Med, Dept Radiol, Seoul, South Korea
- Ryu, JihongUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Chung, Sun JuUniv Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Park, KyemyungUlsan Natl Inst Sci & Technol, Grad Sch Hlth Sci & Technol, Ulsan, South Korea
- Lee, Eun-Jae교신저자Univ Ulsan, Coll Med, Asan Med Ctr, Dept Neurol, Seoul, South Korea
- Cho, HyungJoon교신저자Ulsan Natl Inst Sci & Technol, Grad Sch Hlth Sci & Technol, Ulsan, South Korea
초록
Background: Progressive supranuclear palsy (PSP) is both an underdiagnosed and a frequently misdiagnosed disorder. To remedy these diagnostic limitations, MRI has been used to investigate brain morphology to differentiate PSP from Parkinson's disease (PD) and multiple system atrophy (MSA). However, while nigrostriatal degeneration and tau aggregation are prominent in PSP, and result in iron accumulation and atrophy in the region, substantia nigra (SN) atrophy remains an underexplored diagnostic marker. Purpose: To investigate the diagnostic utility of QSM-derived SN parameters for PSP. Study Type: Retrospective. Population: 123 (59 Males/64 Females) PD patients, 48 (26 M/22 F) MSA patients, and 22 (11 M/11 F) PSP patients were included in the main dataset. MSA patients include 20 parkinsonian type (MSA-P) (11 M/9 F) and 18 cerebellar type (MSA-C) (9 M/9 F) of MSA with 10 undetermined subtype. The external validation set included 12 (6 M/6 F) healthy controls, 13 PD (7 M/6 F), and 10 PSP (6 M/4 F) patients. Field Strength and Sequence: 3 T, MPRAGE T-1-weighted imaging and multi-echo gradient echo imaging (mGRE) for QSM. Assessment: Group level differences of SN volume, magnetic susceptibility, and susceptibility-to-volume ratio (SVR) among PSP, PD, and MSA groups, and these metrics' differentiating power are measured. Bivariate logistic regression with T-1-based morphological markers alongside SN metrics is performed. Statistical Tests: Mann-Whitney U test for group comparisons. Receiver operating characteristic analysis with bootstrapping. p < 0.05 after Bonferroni correction is defined as statistically significant result. Results: The SN SVR was significantly higher in the PSP group compared to the MSA group and the MSA-P group. Moreover, using pons measurements with SN SVR in a bivariate model resulted in the highest differentiation between the PSP and MSA groups (AUC = 0.88, 95% CI: [0.78-0.95]), particularly driven by the increased differentiation between the PSP and MSA-P groups (AUC = 0.88, 95% CI: [0.75-0.98]). External validation supported the generalizability of SN SVR, yielding 100% sensitivity and 80% specificity for differentiating PSP from HC and PD. Data Conclusion: QSM-based SN morphometry can complement T-1-weighted imaging for Parkinsonism assessment. Evidence Level: 3. Technical Efficacy: Stage 2.
키워드
differential diagnosismorphologyparkinsonismquantitative susceptibility mappingsubstantia nigraCLINICAL-DIAGNOSISAUTOPSY
식별자
- Scopus EID
- 2-s2.0-105044896074
- WoS UID
- 001825648000001



로그인
연구물 목록으로